Ten-year experience with transcatheter and surgical aortic valve replacement in Finland

Abstract

Aim: We investigated the outcomes of transcatheter (TAVR) and surgical aortic valve replacement (SAVR) in Finland during the last decade. Methods: The nationwide FinnValve registry included data from 6463 patients who underwent TAVR or SAVR with a bioprosthesis for aortic stenosis from 2008 to 2017. Results: The annual number of treated patients increased three-fold during the study period. Thirty-day mortality declined from 4.8% to 1.2% for TAVR (p =.011) and from 4.1% to 1.8% for SAVR (p =.048). Two-year survival improved from 71.4% to 83.9% for TAVR (p